OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy and safety of exenatide as add‐on therapy for patients with type 2 diabetes with an intensive insulin regimen: A randomized double‐blind trial

HTML

Year: 2020
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.14225
Authors: Michael Joubert, Victoria Opigez, Barbora Pavlikova, Laure Peyro Saint Paul, Nathalie Jeandidier, Anaïs R. Briant, Jean‐Jacques Parienti, Yves Reznik
Institutions: Centre Hospitalier Universitaire de Caen Normandie, Université de Caen Normandie, Charles University, Hôpitaux Universitaires de Strasbourg
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: exenatide, type 2 diabetes, GLP-1 receptor agonists, insulin pump therapy, intensive insulin therapy, adjunctive therapy, glycemic control, HbA1c, body weight, hypoglycemia, gastrointestinal adverse effects, quality of life, drug safety, subcutaneous insulin injection, postprandial blood glucose
SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca
OpenAlex ID: W3092124082
FWCI: 0.748
Cites: 21
Cited by: 13
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security